The University of Rijeka Faculty of Medicine was established in 1955. It is the largest Faculty within the University of Rijeka offering undergraduate studies, postgraduate education, life-long learning and research in the area of biomedicine and health. There are 40 departments and a Center for proteomics, comprising of 180 research staff, 40 postdoctoral fellows and around 70 Ph.D. students. The Faculty of Medicine (MEDRI) attracts external funding from national (84) and international sources (19), including some projects funded under the FP6 and FP7 programmes of the European Commission. Internationally MEDRI is recognized as one of the leading scientific institutions in Croatia. The Faculty of Medicine has a modern infrastructure, a transgenic mice production facility, cell sorter, an antibody production facility, microscopy, a laser capture microdissector, mass spectrometry, informatics support, histology laboratory, pathology etc. The Faculty of Medicine is tightly linked to its educational and research base, the Clinical Hospital Centre Rijeka, which is one of the, two clinical hospital centers in Croatia.  Postgraduate studies (PhD program) are organized at MEDRI and include mandatory and elective subjects, mostly conducted in English. Apart from that, many distinguished scientists in the field of biology and medicine visit the Faculty on the weekly basis, giving talks and discussing research subjects with students and scientists. Several summer schools and international conferences were organized at the Faculty or by the scientists from the Faculty. Within the Faculty campus is also located the recently established modern Laboratory of Mouse Engineering and Breeding Facility (LAMRI) with SPF conditions.

In addition to the TransMedRi project, the Rijeka Faculty of Medicine currently coordinates one other FP7-funded project - CAPRI2010. More information available at  www.capri.com.hr/projects/48-capri2010.html. 

We are also one of the partners in the FP7-funded project INFLA-CARE. More information available at www.molmedbiotech.com.

Our latest research project is NKG2D in T-cells - Memory Control was kicked off on June 1st 2011. It is funded through the Marie Curie Actions - Intra-European Fellowship scheme, under the FP7.